Big Pharma Split Corp.

PRM.TO · TSX
Analyze with AI
Key StatsIncome StatementBalance SheetCash Flow
AnnualQuarterly
KMB
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Assets––––
Cash & EquivalentsCA$2,254CA$1,031CA$1,593CA$204
Short-Term InvestmentsCA$0CA$25,175CA$25,952CA$0
ReceivablesCA$101CA$97CA$62CA$77
InventoryCA$0CA$0CA$0-CA$718
Other Curr. AssetsCA$306-CA$25,175CA$0CA$718
Total Curr. AssetsCA$2,662CA$1,127CA$27,606CA$281
Property Plant & Equip (Net)CA$0CA$0CA$0CA$0
GoodwillCA$0CA$0CA$0CA$0
IntangiblesCA$0CA$0CA$0CA$0
Long-Term InvestmentsCA$23,104CA$25,175CA$42CA$718
Tax AssetsCA$0CA$0CA$0CA$0
Other NC AssetsCA$0CA$0CA$0CA$0
Total NC AssetsCA$23,104CA$25,175CA$42CA$718
Other AssetsCA$0CA$0CA$0CA$0
Total AssetsCA$25,765CA$26,302CA$27,649CA$26,535
Liabilities––––
PayablesCA$0CA$0CA$0CA$249
Short-Term DebtCA$12,252CA$11,573CA$10,718CA$10,297
Tax PayableCA$0CA$0CA$0CA$0
Deferred RevenueCA$0CA$0CA$0-CA$10,049
Other Curr. Liab.CA$369CA$265CA$0-CA$386
Total Curr. Liab.CA$12,622CA$11,839CA$10,718CA$249
LT DebtCA$0CA$0CA$0CA$0
Deferred Rev, NCCA$0CA$0CA$0CA$0
Deferred Tax Liab, NCCA$0CA$0CA$0CA$0
Other NC Liab.CA$91CA$780CA$11,828CA$137
Total NC Liab.CA$91CA$780CA$11,828CA$137
Other LiabilitiesCA$0CA$12,619-CA$10,718CA$0
Cap. LeasesCA$0CA$0CA$0CA$0
Total LiabilitiesCA$12,622CA$12,619CA$11,828CA$10,684
Equity––––
Pref StockCA$0CA$0CA$0CA$0
Common StockCA$13,144CA$13,683CA$15,821CA$15,851
Retained EarningsCA$0CA$0CA$0CA$0
AOCICA$0CA$0CA$0CA$0
Other EquityCA$0CA$0CA$0CA$15,851
Total EquityCA$13,144CA$13,683CA$15,821CA$15,851
Supplemental Information––––
Minority InterestCA$0CA$0CA$0CA$0
Total Liab. & Tot. EquityCA$25,765CA$26,302CA$27,649CA$26,535
Net DebtCA$9,998CA$10,543CA$9,126CA$10,093
Big Pharma Split Corp. (PRM.TO) Financial Statements & Key Stats | AlphaPilot